Ina Perkins - Real Heart MD CEO
HEART Stock | SEK 16.80 1.68 9.09% |
Insider
Ina Perkins is MD CEO of Real Heart
Phone | 46 2 14 75 55 50 |
Web | https://realheart.se |
Real Heart Management Efficiency
The company has return on total asset (ROA) of (0.0775) % which means that it has lost $0.0775 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1447) %, meaning that it generated substantial loss on money invested by shareholders. Real Heart's management efficiency ratios could be used to measure how well Real Heart manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Johan Holmstrom | Xvivo Perfusion AB | 53 | |
Charlotte Walldal | Xvivo Perfusion AB | 56 | |
Fredrik Zetterberg | Episurf Medical AB | 48 | |
Stephen Caswell | Episurf Medical AB | 42 | |
Niklas Carln | Stille AB | 49 | |
Carl Fredin | Bactiguard Holding AB | 57 | |
Mirjam Johansson | SpectraCure AB | N/A | |
Katarina Flodstrm | Episurf Medical AB | 48 | |
Beata Lihammar | Episurf Medical AB | N/A | |
John Anderson | Stille AB | 48 | |
Johan Folkunger | SpectraCure AB | 55 | |
Lotta Bus | BICO Group AB | 53 | |
Kristina Holst | SpectraCure AB | N/A | |
Stefan Grass | Bactiguard Holding AB | 51 | |
Erica Bell | BICO Group AB | 50 | |
Karin Danielsson | BICO Group AB | 41 | |
Johannes Swartling | SpectraCure AB | 51 | |
Patrick Jamnik | Episurf Medical AB | 40 | |
Hector Martinez | BICO Group AB | 38 | |
Sathish Subramaniam | Bactiguard Holding AB | 44 | |
Pal Ryfors | Episurf Medical AB | 40 |
Management Performance
Return On Equity | -0.14 | |||
Return On Asset | -0.0775 |
Real Heart Leadership Team
Elected by the shareholders, the Real Heart's board of directors comprises two types of representatives: Real Heart inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Real. The board's role is to monitor Real Heart's management team and ensure that shareholders' interests are well served. Real Heart's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Real Heart's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ina Perkins, MD CEO | ||
Azad Najar, Chief Founder | ||
Thomas Finocchiaro, Chief Officer | ||
Jonas Bark, Chief Officer |
Real Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Real Heart a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.14 | |||
Return On Asset | -0.0775 | |||
Current Valuation | 76.43 M | |||
Shares Outstanding | 33.18 M | |||
Shares Owned By Insiders | 26.42 % | |||
Shares Owned By Institutions | 3.09 % | |||
Price To Book | 0.85 X | |||
Price To Sales | 9,837 X | |||
Gross Profit | 7.2 M | |||
EBITDA | (10.09 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Real Stock Analysis
When running Real Heart's price analysis, check to measure Real Heart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Real Heart is operating at the current time. Most of Real Heart's value examination focuses on studying past and present price action to predict the probability of Real Heart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Real Heart's price. Additionally, you may evaluate how the addition of Real Heart to your portfolios can decrease your overall portfolio volatility.